Wesley Johnson
Family Medicine · Lexington, KYNPI 1619972171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.
Across 113 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$298
- AstraZeneca$245
- GSK$194
- Johnson & Johnson$183
- Novo Nordisk$140
- AbbVie$128
- plus $804 from 20 others
What the payments were for
- Food & beverage$1,94798%
- Other$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $298 |
| AstraZeneca | 9 | $245 |
| GSK | 7 | $194 |
| Johnson & Johnson | 6 | $183 |
| Novo Nordisk | 9 | $140 |
| AbbVie(2 entities) | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $119 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $72 |
| Boehringer Ingelheim | 3 | $57 |
| Novartis | 4 | $56 |
| Amgen | 3 | $55 |
| Abbott | 4 | $55 |
| Welch Allyn | 1 | $45 |
| Dexcom, Inc. | 1 | $43 |
| Pfizer | 2 | $34 |
| Merck | 2 | $29 |
| Amarin Pharma, Inc. | 1 | $16 |
| Inogen, Inc. | 2 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Seqirus USA Inc | 1 | $11 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,992 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RivastigmineRivastigmine Tartrate | 53 | $1,526 |
| Rosuvastatin Calcium | 56 | $962 |
| Carvedilol | 59 | $188 |
| Atorvastatin Calcium | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lexington
- John RichardLexington$226K
- Susan NeilLexington$18K
- Christopher RhyneLouisville$933K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.